Invitae Corporation (NVTA): Price and Financial Metrics
Invitae Corporation (NVTA)
Today's Latest Price: $17.16 USD
0.13 (0.76%)
Updated Dec 13 12:00am
Add NVTA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 55 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
NVTA Stock Summary
- With a price/sales ratio of 8.8, Invitae Corp has a higher such ratio than 87.74% of stocks in our set.
- With a year-over-year growth in debt of 104.11%, Invitae Corp's debt growth rate surpasses 87.31% of about US stocks.
- Revenue growth over the past 12 months for Invitae Corp comes in at 62.87%, a number that bests 91.48% of the US stocks we're tracking.
- Stocks that are quantitatively similar to NVTA, based on their financial statements, market capitalization, and price volatility, are SENS, DMRC, DOMO, BILI, and CTSO.
- Visit NVTA's SEC page to see the company's official filings. To visit the company's web site, go to www.invitae.com.
NVTA Daily Price Range
NVTA 52-Week Price Range
NVTA Stock Price Chart More Charts
NVTA Price/Volume Stats
| Current price | $17.16 | 52-week high | $28.75 |
| Prev. close | $17.03 | 52-week low | $9.04 |
| Day low | $16.82 | Volume | 885,000 |
| Day high | $17.24 | Avg. volume | 1,914,612 |
| 50-day MA | $17.88 | Dividend yield | N/A |
| 200-day MA | $21.28 | Market Cap | 1.66B |
Invitae Corporation (NVTA) Company Bio
Invitae Corporation is a company that utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for physicians and their patients. The company was founded in 2012 and is based in San Francisco, California.
Top Stories View All
Best & Worst Performing Stock Industries for December 13, 2019
Best & Worst Performing Small Cap Stocks for December 13, 2019
Best & Worst Performing Mid Cap Stocks for December 13, 2019
Best & Worst Performing Large Cap Stocks for December 13, 2019
Best & Worst Performing Mega Cap Stocks for December 13, 2019
View All Top Stories
Loading social stream, please wait...